Choose License Type
The global anesthesia and respiratory devices market was estimated at USD 15.3 billion in 2017, growing at a CAGR of 9.9% during the forecast period from 2019 – 2025. Factors such as increasing prevalence of chronic obstructive pulmonary diseases, growing healthcare awareness, and technological advancements are some of the prominent factors driving the global anesthesia and respiratory devices market. In addition, rising government support for healthcare in emerging economies stimulates the market growth. Government organizations in emerging economies are coming up with favorable healthcare reforms that open new avenues for anesthesia and respiratory device manufacturers in these countries.
Rising incidence of obstructive sleep apnea (OSA) and chronic obstructive pulmonary diseases (COPD) are the some of the major factors propelling the market for respiratory devices market segment globally during the study period. The respiratory devices market segment accounts for the largest share of the global anesthesia and respiratory devices market in 2017. The dominance of this market segment was majorly due to rising healthcare expenditure, especially in the U.S., along with cost effective and convenient medical treatment in a homecare environment, especially amongst the aging population also provides an impetus for growth of the respiratory devices market segment globally. Increasing medical tourism and rising healthcare expenditure in emerging economies for building up the healthcare infrastructure will subsequently drive the demand for anesthesia devices market.
Manufacturers are coming up with newer and technologically advanced devices which are useful and easy to monitor depth of anesthesia on the part of patients during surgery. Increasing awareness about the use of monitoring devices has also caused manufacturers to launch newer products. Ever-increasing awareness amongst people for the use of monitoring devices has accelerated the demand for anesthesia machines. Effective and safe treatment to high risk patients is a major concern amongst anesthesiologists. Hence, there is an increase in the demand for technologically sound and reliable anesthesia machines; which note multiple data about the patient in perioperative environment for effective treatment and critical decision making.
COPD is a degenerative lung disease that causes difficulty in breathing and is one of the leading causes of death. By 2020, COPD is expected to be the third leading cause of death globally. Currently, more than 500 million people worldwide suffer from COPD. The U.S. has the highest number (16.4 million) of people suffering from these diseases. Diagnosis rate of patients suffering from such diseases is increasing at 2% per annum in the developed countries. In emerging markets, it is increasing at more than 13% per annum. Such high incidence triggers demand for respiratory devices globally.
Geographically, North America dominated the global anesthesia and respiratory devices market in 2018 and is expected to retain its dominance during the forecast period. The dominance of this regional market was majorly due to increasing number of patients diagnosed with COPD. In addition, increasing geriatric population and favorable reimbursement policies for anesthesia and respiratory devices in the North American region also support the market growth. Thus, all the above mentioned factors collectively support the dominance of the North American anesthesia and respiratory devices market growth during the forecast period. Asia-Pacific anesthesia and respiratory devices market is estimated to be the most lucrative market owing to rising medical tourism in Asian countries, coupled with increasing government healthcare expenditure boosts the growth of the market in the region.
Key segments of the global anesthesia and respiratory devices market
Device Type Overview, 2015-2025 (USD million)
Regional Overview, 2015-2025 (USD million)
Reasons for the study
• The purpose of the study is to give an exhaustive outlook of the global anesthesia and respiratory devices industry.
• We have been following the overall segmentation of anesthesia and respiratory devices market. The increasing incidences of COPD and OSA and increasing healthcare awareness is expected to drive the market.
• Rising government support and technological advancements are also the prominent factors supporting the growth of the global anesthesia and respiratory devices market.
What does the report include?
• The study on the global anesthesia and respiratory devices market includes qualitative factors such as drivers, restraints, and opportunities
• Additionally, the market has been evaluated using the value chain and Porter’s Five Forces analysis
• The study covers qualitative and quantitative analysis of the market segmented on the basis of anesthesia devices, respiratory devices and region. Moreover, the study provides similar information for the key geographies.
• Actual market sizes and forecasts have been provided for all the above-mentioned segments
• The study includes the profiles of key players in the market with a significant global and/or regional presence
Who should buy this report?
This study is suitable for industry participants and stakeholders in the anesthesia and respiratory devices Industry. The report will benefit:
• Executives of anesthesia and respiratory devices companies that are engaged in the distribution and marketing
• Managers within financial institutions looking to publish recent and forecasted statistics pertaining to anesthesia and respiratory devices.
• Venture capitalist looking into investing capital
• Government organizations, regulatory authorities, policymakers and financial organizations looking for innovative solutions.
• Analysts, researchers, educators, strategy managers, and academic institutions looking for insights into the market to determine future strategies
The global anesthesia and respiratory devices market was estimated at USD 15.3 billion in 2017, growing at a CAGR of 9.9% during the forecast period from 2019 – 2025. Factors such as increasing prevalence of chronic obstructive pulmonary diseases, growing healthcare awareness, and technological advancements are some of the prominent factors driving the global anesthesia and respiratory devices market. In addition, rising government support for healthcare in emerging economies stimulates the market growth. Government organizations in emerging economies are coming up with favorable healthcare reforms that open new avenues for anesthesia and respiratory device manufacturers in these countries.
Rising incidence of obstructive sleep apnea (OSA) and chronic obstructive pulmonary diseases (COPD) are the some of the major factors propelling the market for respiratory devices market segment globally during the study period. The respiratory devices market segment accounts for the largest share of the global anesthesia and respiratory devices market in 2017. The dominance of this market segment was majorly due to rising healthcare expenditure, especially in the U.S., along with cost effective and convenient medical treatment in a homecare environment, especially amongst the aging population also provides an impetus for growth of the respiratory devices market segment globally. Increasing medical tourism and rising healthcare expenditure in emerging economies for building up the healthcare infrastructure will subsequently drive the demand for anesthesia devices market.
Manufacturers are coming up with newer and technologically advanced devices which are useful and easy to monitor depth of anesthesia on the part of patients during surgery. Increasing awareness about the use of monitoring devices has also caused manufacturers to launch newer products. Ever-increasing awareness amongst people for the use of monitoring devices has accelerated the demand for anesthesia machines. Effective and safe treatment to high risk patients is a major concern amongst anesthesiologists. Hence, there is an increase in the demand for technologically sound and reliable anesthesia machines; which note multiple data about the patient in perioperative environment for effective treatment and critical decision making.
COPD is a degenerative lung disease that causes difficulty in breathing and is one of the leading causes of death. By 2020, COPD is expected to be the third leading cause of death globally. Currently, more than 500 million people worldwide suffer from COPD. The U.S. has the highest number (16.4 million) of people suffering from these diseases. Diagnosis rate of patients suffering from such diseases is increasing at 2% per annum in the developed countries. In emerging markets, it is increasing at more than 13% per annum. Such high incidence triggers demand for respiratory devices globally.
Geographically, North America dominated the global anesthesia and respiratory devices market in 2018 and is expected to retain its dominance during the forecast period. The dominance of this regional market was majorly due to increasing number of patients diagnosed with COPD. In addition, increasing geriatric population and favorable reimbursement policies for anesthesia and respiratory devices in the North American region also support the market growth. Thus, all the above mentioned factors collectively support the dominance of the North American anesthesia and respiratory devices market growth during the forecast period. Asia-Pacific anesthesia and respiratory devices market is estimated to be the most lucrative market owing to rising medical tourism in Asian countries, coupled with increasing government healthcare expenditure boosts the growth of the market in the region.
Key segments of the global anesthesia and respiratory devices market
Device Type Overview, 2015-2025 (USD million)
Regional Overview, 2015-2025 (USD million)
Reasons for the study
• The purpose of the study is to give an exhaustive outlook of the global anesthesia and respiratory devices industry.
• We have been following the overall segmentation of anesthesia and respiratory devices market. The increasing incidences of COPD and OSA and increasing healthcare awareness is expected to drive the market.
• Rising government support and technological advancements are also the prominent factors supporting the growth of the global anesthesia and respiratory devices market.
What does the report include?
• The study on the global anesthesia and respiratory devices market includes qualitative factors such as drivers, restraints, and opportunities
• Additionally, the market has been evaluated using the value chain and Porter’s Five Forces analysis
• The study covers qualitative and quantitative analysis of the market segmented on the basis of anesthesia devices, respiratory devices and region. Moreover, the study provides similar information for the key geographies.
• Actual market sizes and forecasts have been provided for all the above-mentioned segments
• The study includes the profiles of key players in the market with a significant global and/or regional presence
Who should buy this report?
This study is suitable for industry participants and stakeholders in the anesthesia and respiratory devices Industry. The report will benefit:
• Executives of anesthesia and respiratory devices companies that are engaged in the distribution and marketing
• Managers within financial institutions looking to publish recent and forecasted statistics pertaining to anesthesia and respiratory devices.
• Venture capitalist looking into investing capital
• Government organizations, regulatory authorities, policymakers and financial organizations looking for innovative solutions.
• Analysts, researchers, educators, strategy managers, and academic institutions looking for insights into the market to determine future strategies
Chapter 1 Executive Summary
Chapter 2 Research Methodology
2.1 Research Methodology
2.1.1 Research Programs/Design
2.1.2 Market Size Estimation
2.2 Research Scope & Assumptions
2.2.1 Research scope
2.2.2 Assumptions
Chapter 3 Market Outlook
3.1 Introduction
3.2 Key Market Trends
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Opportunity
3.3 PESTLE Analysis
3.3.1 Political
3.3.2 Economic
3.3.3 Social
3.3.4 Technology
3.3.5 Legal
3.3.6 Environment
3.4 Patent Analysis
3.5 Porter’s Five Forces Analysis
3.5.1 Bargaining of supplier
3.5.2 Bargaining power of buyers
3.5.3 Threat of new entrant
3.5.4 Competitve Rivalry
3.5.5 Threat of Substitute
3.6 Value Chain Analysis
Chapter 4 Anesthesia and Respiratory Devices Market, by Devices
4.1 Anesthesia Devices
4.1.1 Anesthesia Machines
4.1.1.1 Anesthesia Workstation
4.1.1.2 Anesthesia Delivery Machines
4.1.1.3 Anesthesia Ventilators
4.1.1.4 Anesthesia Monitors
4.1.2 Anesthesia Disposables
4.1.2.1 Anesthesia Masks
4.1.2.2 Anesthesia Accessories
4.2 Respiratory Devices
4.2.1 Respiratory Devices
4.2.1.1 Humidifiers
4.2.1.2 Nebulizers
4.2.1.3 Oxygen Concentrators
4.2.1.4 Positive Airway Pressure Devices
4.2.1.5 Reusable Resuscitators
4.2.1.6 Ventilators
4.2.1.7 Respiratory Inhalers
4.2.2 Respiratory Measurement Devices
4.2.2.1 Pulse Oximetry Systems
4.2.2.2 Capnographs
4.2.2.3 Spirometers
4.2.2.4 Peak Flowmeters
4.2.3 Respiratory Disposables
4.2.3.1 Disposable Oxygen Masks
4.2.3.2 Resuscitaors
4.2.3.3 Tracheostomy Tubes
4.2.3.4 Oxygen Cannula
Chapter 5 Anesthesia and Respiratory Devices Market, by Region
5.1 North America
5.1.1 U.S.
5.1.2 Canada
5.2 Europe
5.2.1 Germany
5.2.2 U.K.
5.2.3 France
5.2.4 Russia
5.2.5 Italy
5.2.6 Rest of Europe
5.3 Asia Pacific
5.3.1 China
5.3.2 Japan
5.3.3 Korea
5.3.4 India
5.3.5 South East Asia
5.3.6 Rest of Asia-Pacific
5.4 South America, Middle-East & Africa
5.4.1 Brazil
5.4.2 Egypt
5.4.3 Saudi Arabia
5.4.4 South Africa
5.4.5 Nigeria
5.4.6 Rest of the World
Chapter 6 Company Profiles
6.1 Acutronic Medical Systems, Inc.
6.1.1 Company Overview
6.1.2 Product Offerings, Application and Features
6.1.3 Recent Initiative
6.1.4 Financial Performance
6.2 Airsep Corporation
6.2.1 Company Overview
6.2.2 Product Offerings, Application and Features
6.2.3 Recent Initiative
6.2.4 Financial Performance
6.3 Amsino International, Inc.
6.3.1 Company Overview
6.3.2 Product Offerings, Application and Features
6.3.3 Recent Initiative
6.3.4 Financial Performance
6.4 Astrazeneca
6.4.1 Company Overview
6.4.2 Product Offerings, Application and Features
6.4.3 Recent Initiative
6.4.4 Financial Performance
6.5 Consort Medical, Inc.
6.5.1 Company Overview
6.5.2 Product Offerings, Application and Features
6.5.3 Recent Initiative
6.5.4 Financial Performance
6.6 GE Healthcare
6.6.1 Company Overview
6.6.2 Product Offerings, Application and Features
6.6.3 Recent Initiative
6.6.4 Financial Performance
6.7 Draeger
6.7.1 Company Overview
6.7.2 Product Offerings, Application and Features
6.7.3 Recent Initiative
6.7.4 Financial Performance